FSMAX
Price
$94.93
Change
-$0.10 (-0.11%)
Updated
Aug 5 closing price
Net Assets
39.63B
TRMSX
Price
$22.42
Change
-$0.11 (-0.49%)
Updated
Aug 5 closing price
Net Assets
306.89M
Interact to see
Advertisement

FSMAX vs TRMSX

Header iconFSMAX vs TRMSX Comparison
Open Charts FSMAX vs TRMSXBanner chart's image
Fidelity Extended Market Index
Price$94.93
Change-$0.10 (-0.11%)
VolumeN/A
Net Assets39.63B
T. Rowe Price Mid-Cap Index I
Price$22.42
Change-$0.11 (-0.49%)
VolumeN/A
Net Assets306.89M
FSMAX vs TRMSX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FSMAX vs. TRMSX commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Hold and TRMSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 39.6B vs. TRMSX (307M). TRMSX pays higher dividends than FSMAX: TRMSX (0.79) vs FSMAX (0.46). FSMAX was incepted earlier than TRMSX: FSMAX (14 years) vs TRMSX (10 years). TRMSX (0.30) is less costly to investors than FSMAX (0.04). TRMSX is a more actively managed with annual turnover of: 31.70 vs. FSMAX (9.00). FSMAX has a lower initial minimum investment than TRMSX: FSMAX (0) vs TRMSX (500000). TRMSX annual gain was more profitable for investors over the last year : 28.09 vs. FSMAX (21.86). TRMSX return over 5 years is better than : 58.15 vs. FSMAX (52.00).
FSMAXTRMSXFSMAX / TRMSX
Total Expense Ratio0.040.1425%
Annual Report Gross Expense Ratio0.040.3012%
Fund Existence14 years10 years-
Gain YTD4.5668.05857%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRAN/AN/A-
Net Assets39.6B307M12,899%
Annual Yield % from dividends0.460.7959%
Returns for 1 year21.8628.0978%
Returns for 3 years38.8447.0882%
Returns for 5 years52.0058.1589%
Returns for 10 years84.21N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LE13.130.46
+3.63%
Lands' End
HALO60.810.82
+1.37%
Halozyme Therapeutics
CHSCP28.590.07
+0.23%
CHS
ICCC6.18-0.06
-0.96%
ImmuCell Corp
SRPT16.75-0.35
-2.05%
Sarepta Therapeutics